| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.6 |